<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-12-20">20 December 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Biruhalem</forename><surname>Assefa</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition at the Center for Cardiovascular Research (CCR)</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ayman</forename><forename type="middle">M</forename><surname>Mahmoud</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition at the Center for Cardiovascular Research (CCR)</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Division of Physiology</orgName>
								<orgName type="department" key="dep2">Department of Zoology</orgName>
								<orgName type="department" key="dep3">Faculty of Science</orgName>
								<orgName type="institution">Beni-Suef University</orgName>
								<address>
									<settlement>Beni-Suef</settlement>
									<country key="EG">Egypt</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">F H</forename><surname>Pfeiffer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbrücke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Section of Metabolic Vascular Medicine</orgName>
								<orgName type="department" key="dep2">Paul Langerhans Institute Dresden (PLID)</orgName>
								<orgName type="institution">Medical Clinic III</orgName>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Dresden University of Technology</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Division of Diabetes &amp; Nutritional Sciences</orgName>
								<orgName type="department" key="dep2">Faculty of Life Sciences &amp; Medicine</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joachim</forename><surname>Spranger</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition at the Center for Cardiovascular Research (CCR)</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition at the Experimental and Clinical Research Centre (ECRC)</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<addrLine>Max-Delbrück Center Berlin-Buch</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Ayman</forename><forename type="middle">M</forename><surname>Arafat</surname></persName>
							<email>ayman.arafat@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition at the Center for Cardiovascular Research (CCR)</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbrücke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-12-20">20 December 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">17A91AA1FC72430FB9C94A4EA10D3163</idno>
					<idno type="DOI">10.1155/2017/3035184</idno>
					<note type="submission">Received 13 September 2017; Accepted 23 October 2017;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Insulin-like growth factor binding protein-2 (IGFBP-2) is the predominant IGF binding protein produced during adipogenesis and is known to increase the insulin-stimulated glucose uptake (GU) in myotubes.</s><s>We investigated the IGFBP-2-induced changes in basal and insulin-stimulated GU in adipocytes and the underlying mechanisms.</s><s>We further determined the role of insulin and IGF-1 receptors in mediating the IGFBP-2 and the impact of IGFBP-2 on the IGF-1-induced GU.</s><s>Fully differentiated 3T3-L1 adipocytes were treated with IGFBP-2 in the presence and absence of insulin and IGF-1.</s><s>Insulin, IGF-1, and IGFBP-2 induced a dose-dependent increase in GU.</s><s>IGFBP-2 increased the insulin-induced GU after long-term incubation.</s><s>The IGFBP-2-induced impact on GU was neither affected by insulin or IGF-1 receptor blockage nor by insulin receptor knockdown.</s><s>IGFBP-2 significantly increased the phosphorylation of PI3K, Akt, AMPK, TBC1D1, and PKCζ/λ and induced GLUT-4 translocation.</s><s>Moreover, inhibition of PI3K and AMPK significantly reduced IGFBP-2-stimulated GU.</s><s>In conclusion, IGFBP-2 stimulates GU in 3T3-L1 adipocytes through activation of PI3K/Akt, AMPK/TBC1D1, and PI3K/PKCζ/λ/GLUT-4 signaling.</s><s>The stimulatory effect of IGFBP-2 on GU is independent of its binding to IGF-1 and is possibly not mediated through the insulin or IGF-1 receptor.</s><s>This study highlights the potential role of IGFBP-2 in glucose metabolism.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Insulin-like growth factor-1 (IGF-1) bears structural homology with proinsulin <ref type="bibr" target="#b0">[1]</ref> and plays a key role in the proliferation and differentiation of adipocytes <ref type="bibr" target="#b1">[2]</ref>.</s><s>In vitro, it is known to exert mitogenic effects at nanomolar concentrations <ref type="bibr" target="#b2">[3]</ref> and to induce insulin-like metabolic effects in both muscle and adipose tissues <ref type="bibr" target="#b3">[4]</ref>.</s><s>The production and secretion of IGF-1 is affected by age, nutritional status, and other hormones <ref type="bibr" target="#b4">[5]</ref>.</s><s>Because of the ability of insulin to induce hepatic growth hormone (GH) receptor gene expression <ref type="bibr" target="#b5">[6]</ref> and protein abundance <ref type="bibr" target="#b6">[7]</ref>, the GH-induced synthesis and release of IGF-1 is highly dependent on the hepatic insulin sensitivity.</s><s>This interplay among GH, insulin, and IGF-1 is of key importance for metabolic and growth regulation <ref type="bibr" target="#b7">[8]</ref>.</s></p><p><s>The bioavailability of IGFs is regulated by a family of seven structurally conserved binding proteins (IGFBPs) <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref>.</s><s>These IGFBPs bind IGF-1 and IGF-2 but not insulin <ref type="bibr" target="#b11">[12]</ref>.</s><s>The IGF-1 independent role of IGFBPs in growth and metabolism has also been reported at least in vitro <ref type="bibr" target="#b13">[13,</ref><ref type="bibr" target="#b14">14]</ref>.</s><s>IGFBP-2 is the predominant binding protein produced during adipogenesis of white preadipocytes <ref type="bibr" target="#b15">[15]</ref>.</s><s>Both inhibitory and stimulatory effects of IGFBP-2 on the cellular actions of IGF-1 and IGF-2 have been reported <ref type="bibr" target="#b16">[16,</ref><ref type="bibr" target="#b17">17]</ref>.</s><s>IGFBP-2 is reported to be a key regulator of metabolic diseases, such as diabetes and obesity.</s><s>Low IGFBP-2 has been shown to be associated with higher fasting glucose levels and reduced insulin sensitivity suggesting it as a biomarker for identification of insulin-resistant individuals <ref type="bibr" target="#b18">[18]</ref>.</s><s>Moreover, IGFBP-2 gene expression was downregulated in visceral white adipose tissue of mice and its circulating levels were reduced in obese ob/ob, db/db, and high fat-fed mice <ref type="bibr" target="#b19">[19]</ref>.</s><s>Low levels of circulating IGFBP-2 have also been reported in obese adults <ref type="bibr" target="#b20">[20]</ref> and children <ref type="bibr" target="#b21">[21]</ref>.</s></p><p><s>Wheatcroft and colleagues demonstrated that IGFBP-2 overexpression conferring protection against age-associated decline in insulin sensitivity in mice <ref type="bibr" target="#b22">[22]</ref>.</s><s>Moreover, the leptin-induced overexpression of IGFBP-2 has been shown to reverse diabetes in insulin-resistant obese mice and hyperinsulinemic clamp studies showed a threefold improvement in hepatic insulin sensitivity following IGFBP-2 treatment of ob/ob mice <ref type="bibr" target="#b23">[23]</ref>.</s><s>However, only few information exists to date regarding the mechanisms underlying the positive IGFBP-2-induced impact on glucose metabolism.</s><s>Indeed, IGFBP-2 has been shown to increase the insulin-stimulated glucose uptake in myotubes <ref type="bibr" target="#b24">[24]</ref> but nothing is known about its impact on glucose uptake in adipocytes with respect to the insulin or IGF-1-induced effects.</s><s>We, therefore, aimed to investigate the IGFBP-2-induced changes in both basal and insulin-stimulated glucose uptake in 3T3-L1 adipocytes and the underlying mechanisms.</s><s>We further investigated the role of insulin and IGF-1 receptors in mediating the IGFBP-2 and even the impact of IGFBP-2 on the IGF-1-induced improvement in glucose uptake.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and Methods</head><p><s>2.1.</s><s>Reagents, Hormones, and Antibodies.</s><s>IGF-1 and IGF-1 Long R3 (IGF-1 LR3) were purchased from BioVision Inc. (Milpitas, CA, USA).</s><s>IGFBP-2, Dulbecco's Modified Eagle Medium (DMEM), penicillin/streptomycin, and fetal bovine serum (FBS) were purchased from Biochrom AG (Berlin, Germany).</s><s>Insulin, dexamethasone, LY294002, and picropodophyllin (PPP) were supplied by Sigma-Aldrich (Darmstadt, Germany).</s><s>3-Isobutyl-1-methylxanthine (IBMX), S961, wortmannin, and Compound C were purchased from Biomol GmbH (Hamburg, Germany), Phoenix Biotech (Beijing, China), Merck Chemicals (Darmstadt, Germany), and BIOZOL Diagnostica Vertrieb (Eching, Germany), respectively.</s><s>RevertAid First Strand cDNA Synthesis Kit, SYBR Green master mix, Bicinchoninic Acid (BCA) protein assay kit, and ECL reagent were supplied by Thermo Fisher Scientific (Dreieich, Germany).</s><s>DNA primers were purchased from Eurogentec Deutschland GmbH (Köln, Germany).</s><s>All other chemicals were supplied by Sigma-Aldrich (Darmstadt, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Cell</head><p><s>Culture.</s><s>The murine fibroblast cell line 3T3-L1 (ATCC, Manassas, VA, USA) was cultured in DMEM supplemented with 4.5 g/L glucose, 10% fetal bovine serum (FBS), 4 mM glutamine, 50 U/ml penicillin, and 50 μg/ml streptomycin until confluence.</s><s>The cells were incubated to differentiate into adipocytes following the method of Woody et al. <ref type="bibr" target="#b25">[25]</ref> with slight modifications.</s><s>Briefly, 2 days postconfluence, cells were treated with 0.5 mM IBMX, 1 μM dexamethasone, and 1 μM insulin supplemented DMEM for 2 days.</s><s>The cells were then maintained in 1 μM insulinsupplemented growth medium for 3 days and in growth medium for 4 days prior to experiments.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">Transfection of Insulin Receptor (INSR) siRNAs.</head><p><s>Differentiated 3T3-L1 adipocytes were transfected with control or INSR specific siRNA (validated siRNA from Dharmacon) using Lipofectamine RNAiMAX (Invitrogen) for 72 h.</s><s>The efficiency of transfection was assessed by using qPCR and Western blot.</s></p><p><s>2.4.</s><s>Measurement of Glucose Uptake.</s><s>Glucose uptake was assayed using the method described by Yamamoto et al. <ref type="bibr" target="#b26">[26]</ref>.</s><s>Briefly, differentiated 3T3-L1 adipocytes were serum starved for 4 h followed by incubation in D-glucose free DMEM for 1 h.</s><s>The adipocytes were washed with PBS (pH 7.4) and then incubated for 30 min in Krebs-Ringer bicarbonate buffer (KRBP) with different concentrations of insulin, IGF-1, IGF-1 LR3 and/or IGFBP-2.</s><s>IGF1 LR3 is an analogue of IGF-1 in which the glutamic acid at carbon 3 (Glu3) is replaced by arginine and contains 13 extra amino acids to the N-terminus.</s><s>It has a very low affinity towards IGFBPs as compared to IGF-1 <ref type="bibr" target="#b27">[27]</ref>.</s><s>The rationale for using IGF1-LR3 was to investigate whether IGFBP-2 is able to impact the IGF-1-induced increase in glucose uptake regardless of its binding to IGF-1 itself.</s><s>Had IGFBP-2 exerted additive effect on the IGF-1-induced glucose uptake, it would be imperative to scrutinize the observed effect as due to binding or other means.</s><s>In some experiments, the adipocytes were incubated with 100 nM S961 (INSR blocker) for 2 h, 60 nM PPP (IGF-1 receptor blocker) for 4 h, 100 μM LY294002 (PI3K inhibitor) for 1 h, 200 nM wortmannin (PI3K inhibitor) for 30 min, or 200 μM Compound C (AMPK inhibitor) for 20 min before the treatment.</s><s>The adipocytes were treated with [ 3 H] 2-Deoxy-D-glucose (0.5 μCi/ml in HEPES) for 10 min at room temperature (RT) and then washed with PBS.</s><s>Thereafter, the cells were lysed in 50 mM NaOH/1% Triton X-100 for scintillation counting using a liquid scintillation counter (PerkinElmer Wallac GmbH, Freiburg, Germany).</s><s>Each experiment was performed with three technical replicates and total number of experiments was three.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Effect of IGFBP-2 on</head><p><s>Basal as well as Insulin and IGF-1-Induced Increase in Glucose Uptake in 3T3-L1 Adipocytes.</s></p><p><s>To study the effect of insulin, IGF-1, IGF-1 LR3, and IGFBP-2 on glucose uptake in 3T3-L1 adipocytes, the cells were incubated with different concentrations of all tested agents for 30 min and [ 3 H] 2-Deoxy-D-glucose uptake was assayed.</s><s>Insulin and IGF-1 were able to exert statistically significant effects on glucose uptake.</s><s>As represented in Figure <ref type="figure" target="#fig_0">1</ref>(a), different concentrations of insulin (10, 20, 50, and 100 nM) were able to exert a significant (P &lt; 0 001) increase in glucose uptake.</s><s>IGF-1 as well produced a significant increase in glucose uptake at either 10 nM (P &lt; 0 05) or higher concentrations (P &lt; 0 001) as depicted in Figure <ref type="figure" target="#fig_0">1(b)</ref>.</s></p><p><s>Treatment of the cells with the lengthened analogue of IGF-1, IGF-1 LR3, induced significant increase in glucose uptake first at higher concentrations (20, 50, and 100 nM) (Figure <ref type="figure" target="#fig_0">1(c)</ref>).</s><s>Similarly, IGFBP-2 was able to significantly (P &lt; 0 01) increase glucose uptake in adipocytes first at a concentration of 100 nM as compared to control cells (Figure <ref type="figure" target="#fig_0">1(d)</ref>).</s></p><p><s>Next, we determined both the short-and long-term impact of IGFBP-2 on insulin, IGF-1, and IGF-1 LR3induced glucose uptake in adipocytes.</s></p><p><s>Short-term incubation of the cells with 1 : 1 stoichiometric ratio of IGFBP-2 and either insulin, IGF-1, or IGF-1 LR3 for 30 min resulted in no additive increase in glucose uptake when compared to insulin, IGF-1, or IGF-1 LR3 alone (Figure <ref type="figure" target="#fig_0">1(e)</ref>).</s></p><p><s>Long-term incubation (24 h) of the cells with IGFBP-2 significantly (P &lt; 0 05) increased basal glucose uptake and exerted an additive effect (P &lt; 0 01) on insulin-stimulated glucose uptake.</s><s>However, adipocytes treated with IGFBP-2 for 24 h showed nonsignificant changes in either IGF-1 or IGF-1 LR3-induced glucose uptake (Figure <ref type="figure" target="#fig_0">1(f))</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">The IGFBP-2-Induced Impact on Glucose Uptake Is Not Mediated through the Activation of Insulin or IGF-1</head><p><s>Receptor.</s><s>To investigate whether the stimulatory effect of IGFBP-2 on glucose uptake is mediated through its binding to insulin or IGF-1 receptors, we incubated 3T3-L1 adipocytes with either insulin receptor blocker (S961) or IGF-1 receptor blocker (PPP).</s></p><p><s>3T3-L1 adipocytes incubated for 2 h with S961 showed a significant (P &lt; 0 05) decrease in basal glucose uptake when compared with the control cells (Figure <ref type="figure" target="#fig_1">2(a)</ref>).</s><s>The insulin receptor blocker S961 significantly reduced insulin (P &lt; 0 001), IGF-1 (P &lt; 0 001), and IGF-1 LR3 (P &lt; 0 01) and stimulated glucose uptake, whereas no impact (P &gt; 0 05) of such treatment on IGFBP-2-stimulated glucose uptake was seen.</s></p><p><s>When compared with S961, the IGF-1 receptor blocker PPP was not able to induce any significant (P &gt; 0 05) effect on glucose uptake in adipocytes neither under basal conditions nor following stimulation with IGF-1, IGF-1 LR3, or IGFBP-2 (Figure <ref type="figure" target="#fig_1">2(b)</ref>).</s></p><p><s>In 3T3-L1 adipocytes transfected with control or INSRspecific siRNA (Figures <ref type="figure" target="#fig_1">2(c</ref>) and 2(d)), insulin (Figure <ref type="figure" target="#fig_1">2(e)</ref>) and IGF-1-stimulated glucose uptake (Figure <ref type="figure" target="#fig_1">2</ref>(f)) were significantly (P &lt; 0 05) reduced, whereas INSR knockdown potentiated the effect of IGFBP-2 on glucose uptake when compared with the control cells (P &lt; 0 01) (Figure <ref type="figure" target="#fig_1">2</ref>(g)).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">IGFBP-2 Stimulates</head><p><s>Glucose Uptake in a PI3K-Dependent Manner.</s><s>Adipocytes treated with insulin and IGF-1 for 30 min exhibited significant (P &lt; 0 001) increase in PI3K phosphorylation when compared with the control cells.</s><s>Similarly, IGFBP-2 induced a significant increase in PI3K phosphorylation in 3T3-L1 adipocytes treated for either 30 min (P &lt; 0 01) or 24 hr (P &lt; 0 001) (Figure <ref type="figure">3(a)</ref>).</s></p><p><s>The effect of PI3K inhibitors (LY294002 and wortmannin) on glucose uptake was investigated to further determine the role of PI3K in mediating the IGFBP-2-stimulated glucose uptake in 3T3-L1 adipocytes.</s><s>Treatment of the adipocytes with either LY294002 (Figure <ref type="figure">3</ref>(b)) or wortmannin (Figure <ref type="figure">3</ref>(c)) induced a significant decline in basal as well as insulin-, IGF-1-, and IGFBP-2-stimulated glucose uptake (P &lt; 0 001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.">IGFBP-2 Induces</head><p><s>Akt and AMPK Phosphorylation and the Subsequent Increase in GLUT-4 Translocation in a PI3K-Dependent Manner.</s><s>We further investigated the impact of IGFBP-2 on Akt and AMPK phosphorylation as well as on GLUT-4 translocation.</s><s>As expected, insulin and IGF-1 significantly (P &lt; 0 001) upregulated Akt phosphorylation in treated 3T3-L1 adipocytes.</s><s>Similarly, IGFBP-2 induced a noticeable increase in Akt phosphorylation in 3T3-L1 adipocytes treated for either 30 min (P &lt; 0 05) or 24h (P &lt; 0 01) (Figure <ref type="figure">4(a)</ref>).</s></p><p><s>IGF-1 significantly (P &lt; 0 001) increased, whereas insulin failed to induce (P &gt; 0 05) AMPK phosphorylation in 3T3-L1 adipocytes (Figure <ref type="figure">4(b)</ref>).</s><s>Similarly, treatment of adipocytes with IGFBP-2 for either 30 min or 24 h induced a significant (P &lt; 0 001) increase in AMPK phosphorylation.</s></p><p><s>To further confirm the involvement of AMPK phosphorylation in IGFBP-2-stimulated glucose uptake, adipocytes were treated with IGFBP-2 with or without previous incubation with the AMPK inhibitor Compound C. Treatment of the 3T3-L1 adipocytes with IGFBP-2 significantly (P &lt; 0 01) increased glucose uptake, an effect that was significantly (P &lt; 0 001) abolished by Compound C (Figure <ref type="figure">3(c)</ref>).</s></p><p><s>Insulin and IGF-1 stimulation increased TBC1D1 phosphorylation significantly (P &lt; 0 05) when compared with the control adipocytes (Figure <ref type="figure">4(d)</ref>).</s><s>Similarly, treatment of the 3T3-L1 adipocytes with IGFBP-2 for either 30 min or 24 h induced a significant (P &lt; 0 05) increase in TBC1D1 phosphorylation (Figure <ref type="figure">4(d)</ref>).</s></p><p><s>GLUT-4 translocation was assessed by subcellular fractionation followed by Western blotting.</s><s>Treatment of</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>6</head><p><s>Oxidative Medicine and Cellular Longevity 3.5.</s><s>IGFBP-2 Stimulates PKCζ/λ Thr410/403 Phosphorylation in 3T3-L1 Adipocytes.</s><s>A significant increase in the phosphorylated levels of the PKCζ/λ isoform was seen after stimulation with insulin (P &lt; 0 05) or IGF-1 (P &lt; 0 01) (Figure <ref type="figure">5</ref>).</s><s>Similarly, treatment of the cells with IGFBP-2 induced a significant increase in PKCζ/λ phosphorylation after either 30 min (P &lt; 0 01) or 24 h (P &lt; 0 001) (Figure <ref type="figure">5</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p><s>Previous studies have indicated the role of IGFBP-2 in adipogenesis and lipogenesis, but its effects on basal glucose uptake and the underlying mechanistic pathways have not yet been addressed.</s><s>We, herein, provide the first evidence for insulin and IGF-1 independent positive impact of IGFBP-2 on glucose uptake in adipocytes.</s><s>We further show that the effect of IGFBP-2 on glucose uptake is mediated through the activation of PI3K/Akt and AMPK pathways.</s><s>Finally, we show that the IGF-1 receptor is neither involved in the IGF-1-induced nor in the IGFBP-2-induced increase in glucose uptake.</s><s>Insulin and IGF-1 exerted significant dose-dependent effects on glucose uptake in 3T3-L1 adipocytes.</s><s>These findings are in agreement with the reports from different previous studies <ref type="bibr" target="#b29">[29]</ref><ref type="bibr" target="#b30">[30]</ref><ref type="bibr" target="#b31">[31]</ref><ref type="bibr" target="#b32">[32]</ref><ref type="bibr" target="#b33">[33]</ref>. Multiple in vivo studies reported the role of IGF-1 in enhancing insulin sensitivity and glucose metabolism.</s><s>A low-serum level of IGF-1 has been associated with insulin resistance, and treatment with recombinant IGF-1 has been shown to improve insulin sensitivity and glucose metabolism <ref type="bibr" target="#b34">[34,</ref><ref type="bibr" target="#b35">35]</ref>.</s><s>A study by Arafat et al. <ref type="bibr" target="#b36">[36]</ref> revealed that long-term treatment of GH-deficient patients with low-dose GH results in improved insulin sensitivity 8</s></p><p><s>Oxidative Medicine and Cellular Longevity and enhanced glucose metabolism.</s><s>This improvement in insulin sensitivity is believed to be mediated by IGF-1, which is secreted as a result of GH stimulation.</s><s>In another clinical study, IGF-1 combined with IGFBP-3 has been shown to improve insulin sensitivity and to reduce complications associated with insulin resistance in HIV/AIDS patients on antiretroviral therapy <ref type="bibr" target="#b37">[37]</ref>.</s><s>Blocking the insulin receptor with S961 or knocking down the INSR using siRNA significantly reduced basal and insulin-stimulated glucose uptake.</s><s>The mechanisms behind the effect of S961 on basal glucose uptake in 3T3-L1 are not known so far.</s><s>However, our results were concordant with previously reported impact of S961 on insulin-stimulated glucose uptake in 3T3-L1 adipocytes <ref type="bibr" target="#b38">[38,</ref><ref type="bibr" target="#b39">39]</ref>.</s><s>Despite the fact that insulin and IGF-1 have different affinities to INSR and IGF-1R, they are able to stimulate both receptors <ref type="bibr" target="#b40">[40]</ref>.</s><s>However, blocking the IGF-1 receptor using PPP <ref type="bibr" target="#b41">[41]</ref> in our present study did not affect the impact of IGF-1 on glucose uptake, whereas blocking or even knocking down the INSR did, pointing to the role of INSR in mediating these IGF-1 effects.</s><s>In the study of Girnita et al. <ref type="bibr" target="#b41">[41]</ref>, PPP efficiently blocked IGF-1R activity and reduced phosphorylation of Akt and extracellular signal-regulated kinase 1 and 2 (Erk1/2) in cultured IGF-1R-positive tumor cells.</s><s>In an in vitro kinase assay, PPP did not affect the INSR or compete with ATP <ref type="bibr" target="#b41">[41]</ref>.</s><s>Our findings are also supported by various reports that demonstrated a dramatic increase in INSR and a decrease in IGF-1R during the transition from preadipocytes to adipocytes in the 3T3-L1 cell line <ref type="bibr" target="#b42">[42]</ref><ref type="bibr" target="#b43">[43]</ref><ref type="bibr" target="#b44">[44]</ref><ref type="bibr" target="#b45">[45]</ref>.</s><s>IGF-1-dependent and independent effects of IGFBPs on metabolism represent a rapidly growing field of research.</s><s>IGFBP-1 was reported to inhibit IGF-1-stimulated glucose uptake but not insulin-stimulated glucose uptake in 3T3-L1 adipocytes <ref type="bibr" target="#b31">[31]</ref>.</s><s>IGFBP-3 can lead to insulin resistance in 3T3-L1 adipocytes as reported by Chan et al. <ref type="bibr" target="#b46">[46]</ref>.</s><s>There is increasing evidence for the role of IGFBP-2 in regulating normal metabolism <ref type="bibr" target="#b47">[47]</ref>.</s><s>Low-serum levels of IGFBP-2 are  9 Oxidative Medicine and Cellular Longevity correlated with obesity <ref type="bibr" target="#b22">[22]</ref>, metabolic syndrome <ref type="bibr" target="#b18">[18]</ref>, and type 2 diabetes <ref type="bibr" target="#b48">[48]</ref>, whereas overexpression of IGFBP-2 protects against diabetes and obesity <ref type="bibr" target="#b22">[22,</ref><ref type="bibr" target="#b23">23]</ref>.</s><s>Roles of IGFBP-2 on metabolism such as inhibition of adipogenesis and lipogenesis <ref type="bibr" target="#b49">[49]</ref>, enhancing insulin-stimulated glucose uptake in skeletal myotubes <ref type="bibr" target="#b50">[50]</ref>, and inhibition of preadipocyte differentiation in vitro <ref type="bibr" target="#b14">[14]</ref> have been reported.</s><s>However, the effects of IGFBP-2 on basal glucose uptake and the mechanisms underlying its IGF-1-independent role on glucose uptake are not well studied.</s><s>Here, we reported significantly increased glucose uptake in 3T3-L1 adipocytes treated with 100 nM IGFBP-2.</s><s>To our knowledge, this is the first report to show the stimulatory effects of IGFBP-2 on basal glucose uptake in adipocytes.</s><s>In addition, our data showed a nonsignificant effect for short-and long-term treatment with IGFBP-2 on IGF-1 and IGF-1 LR3-stimulated glucose uptake.</s><s>Adipocytes treated with IGFBP-2 for 24 h followed by 30 min stimulation with IGF-1 showed a trend increase in glucose uptake.</s><s>Increased basal glucose uptake in control cells incubated with IGFBP-2 for 24 h may explain this increase.</s><s>However, incubation with IGFBP-2 for 24 h exerted a significant additive effect on the insulin-stimulated glucose uptake which coincides with the study of Yau et al. <ref type="bibr" target="#b50">[50]</ref> who reported similar effect for IGFBP-2 in human skeletal muscle cells in vitro.</s><s>It can be postulated that the additive increase in the acute insulin-induced stimulation of glucose uptake after long-term treatment with IGFBP-2 is due to the impact of IGFBP-2 on basal glucose uptake that is likely also mediated through different signaling pathways other than the PI3K/Akt pathway.</s><s>Moreover, these findings provide a notion that IGFBP-2 binding to IGF-1 does not inhibit IGF-1 from exerting its biological role, at least on glucose uptake in vitro.</s></p><p><s>In addition to its ability to bind and modulate the activity of IGFs, IGFBP-2 can bind to proteoglycans <ref type="bibr" target="#b51">[51]</ref> through two heparin-binding domains (HBDs) as well as to integrins through its integrin-binding motif, Gly-Arg-Asp (RGD) <ref type="bibr" target="#b51">[51,</ref><ref type="bibr" target="#b52">52]</ref>.</s><s>This may explain, at least in part, the IGFR-independent IGFBP-2 activities <ref type="bibr" target="#b49">[49]</ref>.</s></p><p><s>Interestingly, neither S961 nor PPP blocked the stimulatory effect of IGFBP-2 on glucose uptake.</s><s>Moreover, INSR knockdown even increased IGFBP-2-induced increase in glucose uptake.</s><s>These findings indicate the involvement of other receptors or pathways in IGFBP-2-stimulated glucose uptake in 3T3-L1 adipocytes.</s><s>This is concordant with the findings of Xi et al. <ref type="bibr" target="#b53">[53]</ref>, who reported that IGFBP-2 stimulates AMPK via its own receptor.</s></p><p><s>Signaling via INSR and IGF-1R shares many common signaling pathways at target cells.</s><s>One of the common pathways in mediating glucose uptake and metabolism is the PI3K pathway <ref type="bibr" target="#b40">[40,</ref><ref type="bibr" target="#b54">54]</ref>.</s><s>Insulin and IGF-1 are known to stimulate the activity of PI3K by triggering its phosphorylation at specific tyrosine residues by upstream components of the INSR and IGF-1R signaling pathways <ref type="bibr" target="#b55">[55]</ref>.</s><s>In the present study, the PI3K inhibitors, LY294002 and wortmannin, reduced basal and insulin, IGF-1, and even IGFBP-2stimulated glucose uptake in adipocytes, pointing to the role of PI3K pathway in mediating the IGFBP-2 effect on glucose uptake.</s><s>We, therefore, investigated the impact of short-and long-term treatment with IGFBP-2 on PI3K phosphorylation in 3T3-L1 adipocytes, using insulin and IGF-1 as controls.</s><s>As expected, treatment of the adipocytes with either insulin or IGF-1 significantly increased PI3K phosphorylation.</s><s>Similarly, IGFBP-2 induced marked increase in PI3K phosphorylation after both short-and long-term treatment, confirming the involvement of PI3K activation in mediating IGFBP-2 effects.</s></p><p><s>Given that IGFBP-2 activates PI3K, we tested its effect on the downstream signaling molecules Akt and AMPK and GLUT-4 translocation.</s><s>As a result of PI3K activation, insulin and IGF-1 stimulated the phosphorylation of Akt.</s><s>These findings are in agreement with the studies of Karlsson et al. <ref type="bibr" target="#b56">[56]</ref> and Zhang et al. <ref type="bibr" target="#b57">[57]</ref>.</s><s>Moreover, IGF-1 significantly increased AMPK phosphorylation.</s><s>IGF-1 has been previously shown to stimulate the phosphorylation of AMPK at its alpha subunit <ref type="bibr" target="#b58">[58]</ref>.</s><s>On the other hand, insulin did not affect the level of p-AMPK indicating that insulin mainly uses the PI3K pathway to exert its effects on glucose metabolism.</s><s>Our findings are in agreement with Shen et al. <ref type="bibr" target="#b59">[59]</ref> who clearly showed that insulin does not stimulate AMPK.</s><s>In the same context, pharmacological activation of AMPK increases glucose uptake in skeletal muscles of subjects with type 2 diabetes <ref type="bibr" target="#b60">[60]</ref> by an insulin-independent mechanism <ref type="bibr" target="#b61">[61]</ref>.</s></p><p><s>Similarly, IGFBP-2 produced a significant increase in Akt phosphorylation which is attributed to its stimulatory effect on PI3K.</s><s>Concordant data were reported by Yau et al. <ref type="bibr" target="#b50">[50]</ref> in human skeletal muscle cells.</s><s>The surface proteoglycan receptor-type protein tyrosine phosphatase β (RPTPβ) has been identified as a functionally active cell surface receptor that links IGFBP-2 and the activation of Akt <ref type="bibr" target="#b62">[62]</ref>.</s><s>IGFBP-2 binds RPTPβ through its HBD, resulting in inhibition of RPTPβ phosphatase activity and subsequently phosphatase and tensin homolog (PTEN) suppression <ref type="bibr" target="#b62">[62]</ref>.</s><s>PTEN is known to prevent Akt activation by dephosphorylating phosphatidylinositol-3,4,5-triphosphate (PIP3).</s><s>The study of Shen et al. <ref type="bibr" target="#b62">[62]</ref> showed that IGFBP-2 −/− mice had increased RPTPβ activity and impaired Akt activation, changes that were reversed by administration of IGFBP-2.</s></p><p><s>In addition, both short-and long-term treatment of the adipocytes with IGFBP-2 induced a significant increase in AMPK phosphorylation.</s><s>IGFBP-2 and IGF-1 have been recently reported by Xi et al. <ref type="bibr" target="#b53">[53]</ref> to induce stimulatory effects on AMPK in osteoblasts.</s><s>Our results were further confirmed through testing the effect of AMPK inhibitor, Compound C, on IGFBP-2-stimulated glucose uptake.</s><s>Incubation of the adipocytes with Compound C significantly abolished IGFBP-2-induced glucose uptake.</s><s>Taken together, AMPK activation plays a potential role in mediating IGFBP-2-stimulated glucose uptake in 3T3-L1 adipocytes.</s></p><p><s>One of the major metabolic changes elicited by AMPK activation is the promotion of glucose uptake <ref type="bibr" target="#b63">[63]</ref>.</s><s>AMPK induces glucose uptake either acutely through GLUT-4 translocation or in the longer term via upregulation of GLUT-4 expression <ref type="bibr" target="#b63">[63]</ref>.</s><s>Here, we show that treatment of the 3T3-L1 adipocytes with IGFBP-2 for 30 min stimulates GLUT-4 translocation to the plasma membrane.</s><s>This effect is attributed to the ability of IGFBP-2 to activate AMPK.</s><s>In 10</s></p><p><s>Oxidative Medicine and Cellular Longevity addition, we show a significant increase in the phosphorylation of the Rab-GAP protein TBC1D1 by IGFBP-2.</s><s>Therefore, the mechanism underlying the IGFBP-2 impact on GLUT-4 translocation and the subsequent promotion of glucose uptake involves the phosphorylation of TBC1D1 at least partly through AMPK-pathway activation.</s><s>This effect is similar to the complementary regulation of TBC1D1 by insulin and AMPK activators <ref type="bibr" target="#b64">[64,</ref><ref type="bibr" target="#b65">65]</ref>.</s><s>Increased TBC1D1 phosphorylation and GLUT-4 translocation by IGFBP-2 could also be directly mediated by Akt activation.</s><s>In the skeletal muscle of rodents, Akt phosphorylates TBC1D1 <ref type="bibr" target="#b66">[66]</ref> which promotes the hydrolysis of guanosine-5 ′ -triphosphate on GLUT-4-containing vesicles <ref type="bibr" target="#b67">[67]</ref>.</s></p><p><s>The atypical protein kinase PKCζ/λ/GLUT-4 is another signaling pathway we thought to have a role in mediating the positive effect of IGFBP-2 on glucose uptake in adipocytes.</s><s>In our study, insulin, IGF-1, and IGFBP-2 induced a significant increase in PKCζ/λ phosphorylation.</s><s>Since, PKCζ/λ is dependent on PI3K activation <ref type="bibr" target="#b29">[29,</ref><ref type="bibr" target="#b68">68]</ref>, it was expected to be activated in adipocytes treated with insulin, IGF-1, and IGFBP-2 because of their ability to activate PI3K.</s><s>Following activation, PI3K signaling diverges into Akt-dependent and PKCζ/λ-mediated pathways <ref type="bibr" target="#b69">[69]</ref>.</s><s>PKCζ/λ is known to play little or no role in mediating insulin effects on glucose uptake in 3T3-L1 adipocytes <ref type="bibr" target="#b70">[70]</ref>, which may explain the IGFBP-2-induced additive increase in the insulin-induced glucose uptake after longterm treatment in our present study.</s><s>However, further studies using inhibitors or gene silencing are needed to explore the precise involvement of PKCζ/λ in mediating the IGFBP-2-induced increase in glucose uptake and GLUT-4 translocation.</s><s>One of the limitations of our study was the IGFBP-2 concentrations used to elicit a significant impact on glucose uptake.</s><s>IGFBP-2 increased glucose uptake at concentrations 7-10-fold higher than those described in humans.</s><s>Therefore, further in vivo studies are needed to explore the precise impact of physiological concentrations of IGFBP-2 on glucose utilization in humans.</s></p><p><s>In summary, this study shows that IGFBP-2 stimulates glucose uptake in 3T3-L1 adipocytes and that synergistic activation of Akt and AMPK mediates the modulatory effect of IGFBP-2.</s><s>The PI3K/PKCζ/λ/GLUT-4 signaling is here shown to mediate the IGFBP-2-induced increase in glucose uptake.</s><s>Furthermore, we showed that IGFBP-2-induced glucose uptake is independent of its binding to IGF-1, INSR, and IGF-1R.</s><s>Our findings highly strengthen the potential and novel role for IGFBP-2 in glucose metabolism.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 :</head><label>1</label><figDesc><div><p><s>Figure 1: Effects of IGFBP-2 on insulin and IGF-1-stimulated glucose uptake in 3T3-L1 adipocytes.</s><s>(a-d) Dose-dependent effects of insulin, IGF-1, IGF-1 LR3, and IGFBP-2 on glucose uptake in 3T3-L1 adipocytes.</s><s>* P &lt; 0 05, * * P &lt; 0 01, and * * * P &lt; 0 001 versus control.</s><s>(e and f) Effect of IGFBP-2 (100 nM) (black bars) on basal and insulin (20 nM), IGF-1 (20 nM), and IGF-1 LR3 (20 nM)-induced glucose uptake (white bars) after short-and long-term incubations.</s><s>* P &lt; 0 05 and * * P &lt; 0 01.</s><s>Each experiment was performed with three technical replicates and total number of experiments was three.</s><s>The glucose uptake values are percentage of the controls.</s><s>The results are presented as mean ± SEM.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 :</head><label>2</label><figDesc><div><p><s>Figure 2: IGFBP-2 stimulates glucose uptake in insulin receptor and IGF-1 receptor-independent mechanism.</s><s>(a) Effect of the insulin receptor (INSR) blocker S961 (black bars) on basal and insulin, IGF-1, IGF-1 LR3, and IGFBP-2-induced glucose uptake (white bars).</s><s>(b) Effect of the IGF-1 receptor blocker PPP (black bars) on basal and insulin, IGF-1, IGF-1 LR3, and IGFBP-2 induced glucose uptake (white bars).</s><s>Differentiated 3T3-L1 adipocytes were incubated with 100 nM S961 for 2 h or 60 nM PPP for 4 h before treatment with insulin, IGF-1, IGF-1 LR3, or IGFBP-2 for 30 min.</s><s>(c and d) Relative mRNA expression, normalized to 36B4, and Western blot analysis of INSR following siRNA transfection, respectively.</s><s>(e, f, and g) Effect of 30 min treatment with insulin, IGF-1, and IGFBP-2 on glucose uptake in control siRNA and INSR siRNA transfected 3T3-L1 adipocytes.</s><s>Each experiment was performed with three technical replicates and total number of experiments was three.</s><s>The glucose uptake values are percentage of the controls.</s><s>The results are presented as mean ± SEM. * P &lt; 0 05, * * P &lt; 0 01, and * * * P &lt; 0 001.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 :Figure 4 :</head><label>34</label><figDesc><div><p><s>Figure3: IGFBP-2 stimulates glucose uptake in a PI3K-dependent manner.</s><s>(a) Insulin, IGF-1, and IGFBP-2 increase the phosphorylation of PI3K.</s><s>3T3-L1 cells were cultured and differentiated in 24-well plates for glucose uptake assay and in 6-well plates for Western blotting analysis.</s><s>The results are presented as mean ± SEM. * P &lt; 0 05, * * P &lt; 0 01, and * * * P &lt; 0 001 versus control.</s><s>(b and c) The PI3K inhibitors, LY294002 and wortmannin (black bars), significantly reduce basal as well as insulin, IGF-1, and IGFBP-2-induced glucose uptake (white bars).</s><s>Differentiated 3T3-L1 adipocytes were incubated with 100 μM LY294002 for 1 h or 200 nM wortmannin for 30 min before treatment with insulin, IGF-1, or IGFBP-2 for 30 min.</s><s>The results are presented as mean ± SEM. * * * P &lt; 0 001.</s><s>Each experiment was performed with three technical replicates and total number of experiments was three.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 :Figure 5 :</head><label>45</label><figDesc><div><p><s>Figure 4: IGFBP-2 stimulates Akt and AMPK activation and thus increased GLUT-4 translocation.</s><s>(a) Insulin, IGF-1, and IGFBP-2 significantly increase Akt Ser473 phosphorylation.</s><s>(b) IGF-1 and IGFBP-2 but not insulin increase AMPK Thr172 phosphorylation.</s><s>* P &lt; 0 05, * * P &lt; 0 01, and * * * P &lt; 0 001 versus control.</s><s>(c) The AMPK inhibitor, Compound C, abolishes IGFBP-2-induced glucose uptake in 3T3-L1 adipocytes.</s><s>Differentiated 3T3-L1 adipocytes were incubated with 200 μM Compound C for 20 min before treatment with IGFBP-2 for 30 min.</s><s>* P &lt; 0 05 and * * * P &lt; 0 001.</s><s>Insulin, IGF-1, and IGFBP-2 significantly increase TBC1D1 Ser237 phosphorylation (d) and GLUT-4 translocation (e).</s><s>* P &lt; 0 05, * * P &lt; 0 01, and * * * P &lt; 0 001 versus control.</s><s>Each experiment was performed with three technical replicates and total number of experiments was three.</s><s>The glucose uptake values are percentage of the controls.</s><s>The results are presented as mean ± SEM.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>Afterwashing, the membranes were developed with an ECL reagent and visualized and densitometry analysis using Image Lab™ Software (Bio-Rad Laboratories GmbH, Munich, Germany) was used to quantify protein signal.</s></p></div></figDesc><table><row><cell>2</cell><cell>Oxidative Medicine and Cellular Longevity</cell></row><row><cell>3T3-L1 adipocytes using TRizol reagent and was treated with</cell><cell></cell></row><row><cell>DNase I. RNA was quantified at 260 nm using a NanoDrop</cell><cell></cell></row><row><cell>(Peqlab Biotechnologie, Erlangen, Germany) and samples</cell><cell></cell></row><row><cell>with A260/A280 ratios &lt; 1.8 were discarded. 1 μg RNA was</cell><cell></cell></row><row><cell>reverse transcribed into cDNA using RevertAid First Strand</cell><cell></cell></row><row><cell>cDNA Synthesis Kit (Thermo Fisher Scientific, Dreieich,</cell><cell></cell></row><row><cell>Germany). cDNA was amplified using SYBR Green master</cell><cell></cell></row><row><cell>mix (Thermo Fisher Scientific, Dreieich, Germany) with the</cell><cell></cell></row><row><cell>primers set outlined in Table 1 and with the following condi-tions: initial denaturation step at 95 °C for 10 min, followed by 40 cycles of 15 sec at 95 °C, 60 sec at annealing temperature of respective primer, and 60 sec at 72 °C for extension. Melting</cell><cell></cell></row><row><cell>curve analysis was used to assess the quality of PCR products</cell><cell></cell></row><row><cell>and the cycle threshold (CT) values were analyzed using the 2 −ΔΔCt method. Data were normalized to 36B4 and presented</cell><cell></cell></row><row><cell>as % of control.</cell><cell></cell></row><row><cell>2.6. Preparation of a Plasma Membrane Fraction for Glucose</cell><cell></cell></row><row><cell>Transporter (GLUT)-4 Translocation Assay. The amount of</cell><cell></cell></row><row><cell>GLUT-4 in the cell membranes was determined using sub-</cell><cell></cell></row><row><cell>cellular fractionation [28] followed by Western blotting</cell><cell></cell></row><row><cell>analysis. Adipocytes were washed 3 times with ice-cold</cell><cell></cell></row><row><cell>HEPES-EDTA-sucrose (HES) buffer (pH 7.4) containing</cell><cell></cell></row><row><cell>proteinase inhibitors. The cell suspension was homogenized</cell><cell></cell></row><row><cell>by passing through 22-gauge needles 10 times on ice. The homogenate was centrifuged at 16000g for 30 min at 4 °C,</cell><cell></cell></row><row><cell>and the pellet was suspended in HES buffer followed by centrifugation at 16000g for 30 min at 4 °C. The pellet was</cell><cell></cell></row><row><cell>resuspended in HES buffer, layered on the top of sucrose</cell><cell></cell></row><row><cell>cushion (38.5% sucrose, 20 mM HEPES and 1 mM EDTA,</cell><cell></cell></row><row><cell>pH 7) in 1 : 1 volume ratio, and centrifuged at 100000g for 1 h at 4 °C. The plasma membrane fraction (middle layer)</cell><cell></cell></row><row><cell>was carefully collected and centrifuged at 40000g for 20 min at 4 °C. The pellet was used to determine the amount of</cell><cell></cell></row><row><cell>GLUT-4 using Western blotting.</cell><cell></cell></row><row><cell>2.7. Western Blot Analysis. Treated 3T3-L1 adipocytes were</cell><cell></cell></row><row><cell>lysed in RIPA buffer supplemented with inhibitors for</cell><cell></cell></row><row><cell>proteinases and phosphatases. For the GLUT-4 translocation</cell><cell></cell></row><row><cell>experiments, the samples were lysed in a specific buffer</cell><cell></cell></row><row><cell>(10 mM Tris-HCl [pH 7.2], 150 mM NaCl, 5 mM EDTA,</cell><cell></cell></row><row><cell>1% Triton X-100, 1% sodium deoxycholate, and 0.1% SDS)</cell><cell></cell></row><row><cell>supplemented with proteinase and phosphatase inhibitors.</cell><cell></cell></row><row><cell>The protein content in the samples was measured by BCA</cell><cell></cell></row><row><cell>assay kit. Proteins (30-50 μg) were denatured and resolved</cell><cell></cell></row><row><cell>in 10% SDS/PAGE and transferred to nitrocellulose mem-</cell><cell></cell></row><row><cell>branes. For GLUT-4, 8% SDS/PAGE was used. Blots were</cell><cell></cell></row><row><cell>blocked for 1 h and probed with 1 : 1000 diluted primary</cell><cell></cell></row><row><cell>antibodies for phosphoinositide 3-kinase (PI3K) p85, phos-</cell><cell></cell></row><row><cell>pho-(Tyr) PI3K p85, protein kinase B (Akt), phospho-Akt</cell><cell></cell></row><row><cell>(Ser473), AMP-activated protein kinase alpha (AMPKα),</cell><cell></cell></row><row><cell>phospho-AMPKα (Thr172), atypical protein kinase (PKCζ),</cell><cell></cell></row><row><cell></cell><cell>2.5. Quantitative Reverse Transcriptase-Polymerase Chain</cell></row><row><cell></cell><cell>Reaction (qRT-PCR) Analysis. Total RNA was isolated from</cell></row></table><note><p><s>phospho-PKCζ/λ (Thr410/403), TBC1D1 (tre-2/USP6, BUB2, cdc16 domain family member 1), phospho-TBC1D1 (Ser237), and GAPDH overnight at 4 °C and with GLUT-4 antibody and Na + /K + -ATPase for 1 h at RT.The blots were washed and incubated with 1 : 2000 diluted corresponding horseradish peroxidase-(HRP-) labeled secondary antibodies.Details of the used antibodies are listed in Table2.2.8.</s><s>Statistical Analysis.</s><s>Data were analyzed for statistical significance by one-way analysis of variance (ANOVA) with Tukey's post hoc test using GraphPad Prism 5 (La Jolla, CA, USA).</s><s>The results were presented as means ± standard error of the mean (SEM) with values of P &lt; 0 05 were considered significant.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 :</head><label>1</label><figDesc><div><p><s>Primers used for qRT-PCR.</s></p></div></figDesc><table><row><cell></cell><cell>3</cell></row><row><cell>Gene</cell><cell>Sequence (5′-3′)</cell></row><row><cell>INSR</cell><cell>F: GTACTGGGAGAGGCAAGCAG R: ACTGGCCGAGTCGTCATACT</cell></row><row><cell>36B4</cell><cell>F: TCATCCAGCAGGTGTTTGACA R: GGCACCGAGGCAACAGTT</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 :</head><label>2</label><figDesc><div><p><s>List of antibodies used.</s></p></div></figDesc><table><row><cell>4</cell><cell></cell><cell cols="2">Oxidative Medicine and Cellular Longevity</cell></row><row><cell>Antibody</cell><cell>Species</cell><cell>Supplier</cell><cell>Catalog number</cell></row><row><cell>Anti-Phospho-AMPKα (Thr172)</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>2535</cell></row><row><cell>Anti-AMPKα</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>2532</cell></row><row><cell>Anti-Phospho-Akt (Ser473)</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>9271</cell></row><row><cell>Anti-Akt</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>9272</cell></row><row><cell>Anti-Phospho-(Tyr) p85 PI3K</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>3821</cell></row><row><cell>Anti-PI3K p85</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>4292</cell></row><row><cell>Anti-Phospho-TBC1D1 (Ser237)</cell><cell>Rabbit</cell><cell>Millipore</cell><cell>07-2268</cell></row><row><cell>Anti-TBC1D1</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>5929</cell></row><row><cell>Anti-Phospho-PKCζ/λ (Thr410/403)</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>9378</cell></row><row><cell>Anti-PKCζ</cell><cell>Mouse</cell><cell>Santa Cruz Biotechnology</cell><cell>SC-17781</cell></row><row><cell>Anti-GLUT-4</cell><cell>Rabbit</cell><cell>Sigma</cell><cell>G4173</cell></row><row><cell>Anti-Na + , K + -ATPase</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>3010</cell></row><row><cell>Anti-GAPDH</cell><cell>Rabbit</cell><cell>Cell Signaling Technology</cell><cell>2118</cell></row><row><cell>Goat anti-rabbit IgG HRP-linked</cell><cell>Goat</cell><cell>Cell Signaling Technology</cell><cell>4074</cell></row><row><cell>Horse anti-mouse IgG HRP-linked</cell><cell>Horse</cell><cell>Cell Signaling Technology</cell><cell>4076</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The authors would like to thank Dr. Michael Laue and Lars Möller from the Robert Koch Institute (Berlin) for their technical support during subcellular fractionation procedures.</s><s>Biruhalem Assefa and Ayman M. Arafat were funded by the graduate school Grant no.</s><s>1208/2 from the German Research Foundation (DFG).</s><s>Ayman M. Mahmoud is funded by a postdoctoral fellowship (ID 1158232) from the Alexander Von Humboldt Foundation.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of Interest</head><p><s>The authors have declared that no competing interests exist.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' Contributions</head><p><s>Ayman M. <ref type="bibr">Arafat</ref></s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin</title>
		<author>
			<persName><forename type="first">E</forename><surname>Rinderknecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Humbel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">253</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2769" to="2776" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Wise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Berkowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Rubin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">263</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="9402" to="9408" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Insulin-like growth factor II (IGF-II)</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>O'dell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N M</forename><surname>Day</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Biochemistry &amp; Cell Biology</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="767" to="771" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">IGFs and IGFBPs: role in health and disease</title>
		<author>
			<persName><forename type="first">R</forename><surname>Monzavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cohen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="433" to="447" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Biosynthesis of growth hormone and insulin-like growth factor-I and the regulation of their secretion</title>
		<author>
			<persName><forename type="first">A</forename><surname>Skottner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Open Endocrinology Journal</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="3" to="12" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Insulin restores GH responsiveness during lactation-induced negative energy balance in dairy cattle: effects on expression of IGF-I and GH receptor 1A</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Butler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Marr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Pelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Radcliff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Lucy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Butler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Endocrinology</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="205" to="217" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Insulin increases the abundance of the growth hormone receptor in liver and adipose tissue of periparturient dairy cows</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Rhoads</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Leury</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Nutrition</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1020" to="1027" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Clemmons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Investigation</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="25" to="27" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">IGF-binding proteins -the pieces are falling into place</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Bach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Headey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Norton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Trends in Endocrinology &amp; Metabolism</title>
				<imprint>
			<date type="published" when="2005">2005</date>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="228" to="234" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Circulating IGF-binding protein 7 (IGFBP7) levels are elevated in patients with endometriosis or undergoing diabetic hemodialysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kutsukake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ishihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Momose</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Reproductive Biology and Endocrinology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">54</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Role of IGF binding proteins in regulating metabolism</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Clemmons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends in Endocrinology &amp; Metabolism</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="375" to="391" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The insulin-like growth factor system and its pleiotropic functions in brain</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Gluckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Werther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrine Reviews</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="916" to="943" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Oxidative Medicine and Cellular Longevity</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mohan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Baylink</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Endocrinology</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="19" to="31" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Wheatcroft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Kearney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Trends in Endocrinology &amp; Metabolism</title>
				<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="153" to="162" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Boney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Moats-Staats</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Stiles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>D'ercole</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1863" to="1868" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hoeflich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Reisinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lahm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="8601" to="8610" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma</title>
		<author>
			<persName><forename type="first">T</forename><surname>Fukushima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kataoka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anticancer Research</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">6A</biblScope>
			<biblScope unit="page" from="3685" to="3692" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Heald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kaushal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Siddals</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Rudenski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gibson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Experimental and Clinical Endocrinology &amp; Diabetes</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">07</biblScope>
			<biblScope unit="page" from="371" to="376" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Picard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hormone and Metabolic Research</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="787" to="791" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Nam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Obesity</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="355" to="359" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Adipocytes IGFBP-2 expression in prepubertal obese children</title>
		<author>
			<persName><forename type="first">M</forename><surname>Claudio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Benjamim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Riccardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Massimiliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Francesco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Luciano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obesity</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2055" to="2057" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">IGFbinding protein-2 protects against the development of obesity and insulin resistance</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Wheatcroft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Kearney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Shah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="285" to="294" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Antidiabetic effects of IGFBP2, a leptin-regulated gene</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hedbacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Birsoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Wysocki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metabolism</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="22" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">IGFBP-2 enhances insulin signalling and glucose uptake in human skeletal myotubes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Yau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Werther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sabin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obesity Research &amp; Clinical Practice</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="e44" to="e45" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Regulation of myosin light chain kinase during insulin-stimulated glucose uptake in 3T3-L1 adipocytes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Woody</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Stall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ramos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Patel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">e77248</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Measurement of glucose uptake in cultured cells</title>
		<author>
			<persName><forename type="first">N</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sato</surname></persName>
		</author>
		<idno>12.14 11-12.14.22</idno>
	</analytic>
	<monogr>
		<title level="j">Current Protocols in Pharmacology</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Solution structure and backbone dynamics of long-[Arg 3 ]insulin-like growth factor-I</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Laajoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Francis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Carver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Keniry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="10009" to="10015" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Insulinmediated translocation of glucose transporters from intracellular membranes to plasma membranes: sole mechanism of stimulation of glucose transport in L6 muscle cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ramlal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sarabia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Bilan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Klip</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1329" to="1335" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Requirement of atypical protein kinase Cλ for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kotani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ogawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Matsumoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="6971" to="6982" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">IGF-I regulates IRS-1 expression in 3T3-L1 adipocytes</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Garner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<imprint>
			<biblScope unit="volume">255</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="614" to="617" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Siddals</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Westwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>White</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Endocrinology</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="289" to="297" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takahashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Letters</title>
		<imprint>
			<biblScope unit="volume">582</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="573" to="578" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Dimethyl sulfoxide enhances GLUT4 translocation through a reduction in GLUT4 endocytosis in insulin-stimulated 3T3-L1 adipocytes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Berenguer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Bruce</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochimie</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="697" to="709" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Dunger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Growth Hormone &amp; IGF Research</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="S55" to="S61" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>Supplement A</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Dunger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes, Obesity and Metabolism</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="22" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Arafat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Möhlig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Weickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schöfl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Spranger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Pfeiffer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1304" to="1313" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mulligan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Tai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="4361" to="4366" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">A novel highaffinity peptide antagonist to the insulin receptor</title>
		<author>
			<persName><forename type="first">L</forename><surname>Schäffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Brand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Hansen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<imprint>
			<biblScope unit="volume">376</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="380" to="383" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Agonism and antagonism at the insulin receptor</title>
		<author>
			<persName><forename type="first">L</forename><surname>Knudsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">12</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances</title>
		<author>
			<persName><forename type="first">K</forename><surname>Siddle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Endocrinology</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">34</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Cyclolignans as inhibitors of the insulinlike growth factor-1 receptor and malignant cell growth</title>
		<author>
			<persName><forename type="first">A</forename><surname>Girnita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Girnita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Prete</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bartolazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Axelson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="236" to="242" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kaufmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Mackall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Student</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Lane</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="4876" to="4880" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Boney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Gruppuso</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1638" to="1644" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Huo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death and Differentiation</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="714" to="723" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Insulin and insulinlike growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription</title>
		<author>
			<persName><forename type="first">J</forename><surname>Boucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Kahn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="17235" to="17245" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Insulinlike growth factor binding protein-3 leads to insulin resistance in adipocytes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Twigg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Firth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Baxter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="6588" to="6595" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">IGFBP-2 at the interface of growth and metabolism-implications for childhood obesity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sabin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Azar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Yau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kiess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Werther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatric Endocrinology Reviews</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="382" to="393" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Frystyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Skjaerbaek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vestbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fisker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Orskov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes/Metabolism Research and Reviews</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="314" to="322" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Yau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Dunshea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Werther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sabin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Obesity</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="770" to="781" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">IGFBP-2 enhances insulin signalling pathways in human skeletal muscle by cell surface binding -an IGF-independent process?</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Yau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Werther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sabin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Endocrine Society&apos;s 96th Annual Meeting and Expo</title>
				<meeting><address><addrLine>Chicago, IL, USA</addrLine></address></meeting>
		<imprint>
			<publisher>Endocrine Society</publisher>
			<date type="published" when="2014">2014</date>
			<biblScope unit="page">1072</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Schütt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Andaloro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4445" to="4455" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Schutt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Langkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Rauschnabel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Ranke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Elmlinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Endocrinology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="859" to="868" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">IGF-I and IGFBP-2 stimulate AMPK activation and autophagy, which are required for osteoblast differentiation</title>
		<author>
			<persName><forename type="first">G</forename><surname>Xi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Clemmons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="268" to="281" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Signalling by insulin and IGF receptors: supporting acts and new players</title>
		<author>
			<persName><forename type="first">K</forename><surname>Siddle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Endocrinology</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="R1" to="R10" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dupont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Leroith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hormone Research in Paediatrics</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="22" to="26" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Karlsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Zierath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Lienhard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wallberg-Henriksson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1692" to="1697" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Effects of insulin and IGF-I on growth hormone-induced STAT5 activation in 3T3-F442A adipocytes</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lipids in Health and Disease</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">56</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">IGF-1 phosphorylates AMPK-α subunit in ATM-dependent and LKB1-independent manner</title>
		<author>
			<persName><forename type="first">A</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kusakai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kishimoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="986" to="992" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Cinnamon extract enhances glucose uptake in 3T3-L1 adipocytes and C2C12 myocytes by inducing LKB1-AMP-activated protein kinase signaling</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Honma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kobayashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e87894</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">5-aminoimidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Koistinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Galuska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Chibalin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1066" to="1072" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Hirshman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Kurth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Winder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Goodyear</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1369" to="1373" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-Istimulated signaling</title>
		<author>
			<persName><forename type="first">X</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Xi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Maile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Clemmons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="4116" to="4130" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">AMPactivated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Mcgee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Van Denderen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Howlett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="860" to="867" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Toth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Morrice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mackintosh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical Journal</title>
		<imprint>
			<biblScope unit="volume">409</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="449" to="459" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Genetic disruption of AMPK signaling abolishes both contraction-and insulinstimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pehmoller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Treebak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Birk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Physiology -Endocrinology and Metabolism</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="E665" to="E675" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Kramer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="9787" to="9796" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="14599" to="14602" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ishiki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Klip</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="5071" to="5078" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-ζ</title>
		<author>
			<persName><forename type="first">G</forename><surname>Bandyopadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Standaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Sajan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Endocrinology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1766" to="1772" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Role of PKC isoforms in glucose transport in 3T3-L1 adipocytes: insignificance of atypical PKC</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tsuru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Katagiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Asano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Physiology -Endocrinology and Metabolism</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="E338" to="E345" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Oxidative Medicine and Cellular Longevity</title>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
